E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor

Heparosan is an acidic polysaccharide natural product, which serves as the critical precursor in heparin biosynthesis and in the chemoenzymatic synthesis of bioengineered heparin. Heparosan is also the capsular polysaccharide of Escherichia coli K5 strain. The current study was focused on the examination of the fermentation of E. coli K5 with the goal of producing heparosan in high yield and volumetric productivity. The structure and molecular weight properties of this bacterial heparosan were determined using polyacrylamide gel electrophoresis (PAGE) and Fourier transform mass spectrometry. Fermentation of E. coli K5 in a defined medium using exponential fed‐batch glucose addition with oxygen enrichment afforded heparosan at 15 g/L having a number average molecular weight of 58,000 Da and a weight average molecular weight of 84,000 Da. Biotechnol. Bioeng. 2010;107: 964–973. © 2010 Wiley Periodicals, Inc.

[1]  R. Linhardt,et al.  Analysis of E. coli K5 capsular polysaccharide heparosan , 2011, Analytical and bioanalytical chemistry.

[2]  Zhenqing Zhang,et al.  Nuclear magnetic resonance quantification for monitoring heparosan K5 capsular polysaccharide production. , 2010, Analytical biochemistry.

[3]  S. Bhattacharyya,et al.  Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. , 2010, American journal of respiratory cell and molecular biology.

[4]  R. Linhardt,et al.  Recent progress and applications in glycosaminoglycan and heparin research. , 2009, Current opinion in chemical biology.

[5]  R. Langer,et al.  Orthogonal analytical approaches to detect potential contaminants in heparin , 2009, Proceedings of the National Academy of Sciences.

[6]  Zhenqing Zhang,et al.  Structural Snapshots of Heparin Depolymerization by Heparin Lyase I* , 2009, The Journal of Biological Chemistry.

[7]  Haiying Liu,et al.  Lessons learned from the contamination of heparin. , 2009, Natural product reports.

[8]  M. Goldrick,et al.  The Escherichia coli K5 Capsule Is Not Synthesized in a Protected Compartment within the Cytoplasm , 2008, Journal of bacteriology.

[9]  Jesús Jiménez-Barbero,et al.  Solution structures of chemoenzymatically synthesized heparin and its precursors. , 2008, Journal of the American Chemical Society.

[10]  R. Langer,et al.  Contaminated heparin associated with adverse clinical events and activation of the contact system. , 2008, The New England journal of medicine.

[11]  Robert Langer,et al.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events , 2008, Nature Biotechnology.

[12]  I. Roberts,et al.  The cell surface expression of group 2 capsular polysaccharides in Escherichia coli: the role of KpsD, RhsA and a multi‐protein complex at the pole of the cell , 2006, Molecular microbiology.

[13]  Joseph Shiloach,et al.  Growing E. coli to high cell density--a historical perspective on method development. , 2005, Biotechnology advances.

[14]  M. Salmivirta,et al.  Generation of "neoheparin" from E. coli K5 capsular polysaccharide. , 2005, Journal of medicinal chemistry.

[15]  R. Linhardt,et al.  Role of glycosaminoglycans in cellular communication. , 2004, Accounts of chemical research.

[16]  M. Manzoni,et al.  Influence of the culture conditions on extracellular lyase activity related to K5 polysaccharide , 2004, Biotechnology Letters.

[17]  Michael J Cooney,et al.  Tracking the acetate threshold using DO‐transient control during medium and high cell density cultivation of recombinant Escherichia coli in complex media , 2003, Biotechnology and bioengineering.

[18]  R. Linhardt 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. , 2003, Journal of medicinal chemistry.

[19]  C. White,et al.  Identification and Molecular Cloning of a Heparosan Synthase fromPasteurella multocida Type D* , 2002, The Journal of Biological Chemistry.

[20]  W. Johnston,et al.  Industrial control of recombinant E. coli fed-batch culture: new perspectives on traditional controlled variables , 2002, Bioprocess and biosystems engineering.

[21]  S. Olson,et al.  Heparin Enhances the Specificity of Antithrombin for Thrombin and Factor Xa Independent of the Reactive Center Loop Sequence , 2001, The Journal of Biological Chemistry.

[22]  R. P. Silver,et al.  ABC transporters and the export of capsular polysaccharides from gram-negative bacteria. , 2001, Research in microbiology.

[23]  C. Arrecubieta,et al.  The Transport of Group 2 Capsular Polysaccharides across the Periplasmic Space in Escherichia coli , 2001, The Journal of Biological Chemistry.

[24]  N. Cook,et al.  Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha -UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. , 2000, The Journal of biological chemistry.

[25]  I. Roberts,et al.  Regulation of the Escherichia coli K5 Capsule Gene Cluster: Evidence for the Roles of H-NS, BipA, and Integration Host Factor in Regulation of Group 2 Capsule Gene Clusters in Pathogenic E. coli , 2000, Journal of bacteriology.

[26]  I S Roberts,et al.  Structure, assembly and regulation of expression of capsules in Escherichia coli , 1999, Molecular microbiology.

[27]  L. Kjellén,et al.  Regulated Diversity of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[28]  S. Lee,et al.  High cell density culture of metabolically engineered Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium. , 1998, Biotechnology and bioengineering.

[29]  M. Kaghad,et al.  N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression , 1996, Journal of bacteriology.

[30]  M. Manzoni,et al.  Production of K5 Polysaccharides of Different Molecular Weight by Escherichia Coli , 1996 .

[31]  A. Shashkov,et al.  Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: reexamination , 1996, Journal of bacteriology.

[32]  E. Vimr,et al.  Thermoregulation of kpsF, the first region 1 gene in the kps locus for polysialic acid biosynthesis in Escherichia coli K1 , 1996, Journal of bacteriology.

[33]  S. Lee,et al.  High cell-density culture of Escherichia coli. , 1996, Trends in biotechnology.

[34]  U. Rinas,et al.  Simple fed-batch technique for high cell density cultivation of Escherichia coli. , 1995, Journal of biotechnology.

[35]  M. Manzoni,et al.  Extracellular K5 Polysaccharide of Escherichia coli: Production and Characterization , 1993 .

[36]  A. Finke,et al.  Biosynthesis of the Escherichia coli K5 polysaccharide, a representative of group II capsular polysaccharides: polymerization in vitro and characterization of the product , 1991, Journal of bacteriology.

[37]  K. Jann,et al.  Structure and biosynthesis of the capsular antigens of Escherichia coli. , 1990, Current topics in microbiology and immunology.

[38]  K. Yoshida,et al.  Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. , 1989, Analytical biochemistry.

[39]  C. Cooney,et al.  Polysaccharide lyases , 1986, Applied biochemistry and biotechnology.

[40]  M. Schmidt,et al.  Phospholipid substitution of capsular (K) polysaccharide antigens from Escherichia coli causing extraintestinal infections , 1982 .

[41]  M. Schmidt,et al.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.

[42]  M. Schmidt,et al.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.

[43]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.

[44]  R. Linhardt Heparin : Structure and Activity , 2022 .